CASES

Proxima delivered a business assessment and go-to-market strategies to support the launch of a new product in Latin America for a company based in India. The market entry strategy was designed for each country and the project unfolded in the selection of key personnel for strategic positions.

With our strong pharmaceutical network and market knowledge, we recently supported a client to identify potential companies for acquisition in the Brazilian pharmaceutical market. The project scope included stewardship to enable strategic connections and streamline the acquisition process.

Proxima crafted a comprehensive evaluation to support the introduction of a new Covid-19 vaccine in Latin American markets. We designed entry strategies for each country, outlined regulatory landscapes, and pinpointed potential partnerships to assure market coverage.

Proxima skills in market assessment and business development were put to practice when we assisted a publicly listed Brazilian biologics company to expand into new market segments with its existing portfolio. The project deliverables included the identification of growth opportunities and the realignment of products with market demands for optimized impact.

Proxima conducted an in-depth market analysis and competitive benchmarking to support a global pharmaceutical client in optimizing their product launch strategy across multiple regions. The project involved identifying key market drivers, assessing competitive positioning, and tailoring product messaging to resonate with target audiences.We leveraged insights to refine the go-to-market strategy and maximize product adoption in high-growth segments, ultimately supporting the client’s strategic objectives for market share expansion and profitability.

Proxima’s role in this project was to stimulate and support in-depth strategic planning exercises for Rio de Janeiro’s Commercial Association to identify and develop new revenue streams.